title: [Positron emission tomography using 18F-fluorodeoxyglucose in the management of nonsmall cell lung cancers in 2006].
abstract: Technological progress and numerous published studies allow to estimate the best place of the 18F-fluorodeoxyglucose positron emission tomography, a real functional metabolic imagery, in the clinical and therapeutic strategy of non small cell lung cancers.
authors.affiliation: Service des maladies respiratoires, hôpital d'instruction des armées Percy, 101, avenue Henri-Barbusse, 92141 Clamart, France. vaylet.fabien@gmail.com
authors.forename: F
authors.initials: F
authors.lastname: Vaylet
authors.forename: A
authors.initials: A
authors.lastname: Bonnichon
authors.forename: Y
authors.initials: Y
authors.lastname: Salles
authors.forename: E
authors.initials: E
authors.lastname: Gontier
authors.forename: G
authors.initials: G
authors.lastname: Bonardel
authors.forename: H
authors.initials: H
authors.lastname: Lefloch
authors.forename: A
authors.initials: A
authors.lastname: Mairovitz
authors.forename: M
authors.initials: M
authors.lastname: Mantzarides
authors.forename: A
authors.initials: A
authors.lastname: Niang
authors.forename: C
authors.initials: C
authors.lastname: Marotel
authors.forename: H
authors.initials: H
authors.lastname: Foehrenbach
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000000981:diagnostic imaging* / Q000556:secondary; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D009367:Neoplasm Staging; D010347:Patient Care Planning; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18